# A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects

> **NCT02571140** · PHASE1 · COMPLETED · sponsor: **Entera Bio Ltd.** · enrollment: 30 (actual)

## Conditions studied

- Drug Safety and Bioavailability

## Interventions

- **DRUG:** Teriparatide
- **DRUG:** Oral PTH (1-34)

## Key facts

- **NCT ID:** NCT02571140
- **Lead sponsor:** Entera Bio Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2017-08
- **Final completion:** 2017-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02571140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02571140, "A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT02571140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*